Summary
Stimulation of 5-HT1A receptors is known to decrease the arterial blood pressure in anaesthetized rats, cats and dogs. We investigated the hypotensive activity of flesinoxan (0.1 + 0.2 + 0.7 μmol/kg), a 5-HT1A-receptor agonist, in dogs anaesthetized with either morphine and pentobarbital or enflurane and also in the conscious state. Flesinoxan led to a decrease in arterial blood pressure in anaesthetized, but not in conscious dogs. In the conscious state the marked increase in heart rate, which can be taken as an indicator of sympathetic tone, may have masked the consequences of vasodilatation. These different haemodynamic responses to flesinoxan may be dependent on side effects of the drug in the conscious dogs, in particular hyperventilation and salivation combined with anxiety, and on the magnitude of the decrease in baroreceptor reflex activity during anaesthesia with morphine and pentobarbital on the one hand and enflurane on the other hand.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beck A, Zimpfer M, Raberger G (1982) Inhibition of the carotid chemoreceptor reflex by enflurane in chronically instrumented dogs. Naunyn-Schmiedeberg's Arch Pharmacol 321:145–148
Bevan P, Ramage AG, Wouters W (1986a) Investigation of the effects of DU 29373 on the cardiovascular system of the anaesthetized cat. Br J Pharmacol 89:506
Bevan P, Tulp, MTHM, Wouters W (1986b) Are 5-HTIA binding sites relevant for the antihypertensive effects of DU 29373? Br J Pharmacol 89:637
Calis JIM, Hartog J, Janszen FHA, Wouters W (1986) Cardiovascular effects of the new antihypertensive compound DU 29373. Br J Pharmacol 89:496
De Voogd JM, Prager G (1990) Early clinical experience with flesinoxan, a new selective 5-HT1A receptor agonist. In: Saxena PR, Wallis DA, Wouters W, Bevan P (eds) Cardiovascular pharmacology of 5-HT. Kluwer Academic Press, Dordrecht, The Netherlands, pp 355–359
Di Francesco GF, Petty MA, Fozard JR (1988) Antihypertensive effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OHDPAT) in conscious dogs. Eur J Pharmacol 147:287–290
Fozard JR, Mir AK, Middlemiss DN (1987) Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OHDPAT) in the rat: site of action and pharmacological analysis. J Cardiovasc Pharmacol 9:328–346
Gillis RA, Kellar KJ, Quest JA, Namath IJ, Martino-Barrows A, Hill K, Gatti PJ, Dretchen K (1988a) Experimental studies on the neurocardiovascular effects of urapidil. Drugs 35 [Suppl 20] 20–33
Gillis RA, Hill KJ, Kirby JS, Quest JA, Hammosh P, Norman WP, Kellar KJ (1988b) Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function. J Pharmacol Exp Ther 248:851–857
Grohs JG, Raberger G (1989) Central 5-HTIA-receptor stimulation exerts no blood pressure reduction in conscious dogs. Naunyn-Schmiedeberg's Arch Pharmacol 339:R62
Grohs JG, Fischer G, Rahberger G (1989) Cardiac and hemodynamic effects of the bradycardic agent KC 8857 during exercise-induced myocardial ischemia. Eur J Pharmacol 161:53–60
Holm S (1979) A simple sequentially rejective multiple test procedure. Scand Statist 6:65–70
Laubie M, Drouillat M, Dabire H, Cherqui C, Schmitt H (1989) Ventrolateral medullary pressor area: site of hypotensive and sympatho-inhibitory effects of 8-OH-DPAT in anaesthetized dogs. Eur J Pharmacol 160:385–393
Mason DT, Spann JF, Zelis R (1970) Quantification of contractile state of the intact human heart. Am J Cardiol 26:248–257
McCall RB, Patel BN, Harris LT (1987) Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. J Pharmacol Exp Ther 242:1152–1159
Morton M, Duke PC, Ong B (1980) Baroreflex control of heart rate in man awake and during enflurane and enflurane-nitrous oxide anesthesia. Anesthesiology 32:221–223
Petty MA, Kintz J, Di Francesco GF, Fozard JR (1988) Comparison between the cardiovascular effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and clonidine in the conscious sino-aortic denervated rat. J Auton Pharmacol 8:267–276
Ramage AG, Fozard JR (1987) Evidence that the putative 5-HTIA receptor agonist, 8-OH-DPAT and ipsapirone, have a central hypotensive action that differs from that of clonidine in anaesthetized cats. Eur J Pharmacol 138:179–190
Skavsted P, Price HL (1972) The effects of ethrane on arterial pressure, preganglionic sympathetic activity, and barostatic reflexes. Anesthesiology 36:257–262
Wouters W, Hartog J, Bevan P (1988) Flesinoxan. Cardiovasc Drug Rev 6:71–83
Zimpfer M, Beck A, Mayer N, Raberger G, Steinbereithner K (1983) Einfluß von Morphium auf die Kontrolle des kardiovaskulären Systems durch den Carotis-Sinus-Reflex und den Carotis-Chemoreflex. Anaesthesist 32:60–66
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grohs, J.G., Fischer, G. & Raberger, G. Cardiovascular effects of flesinoxan in anaesthetized and conscious dogs. Naunyn-Schmiedeberg's Arch Pharmacol 341, 472–475 (1990). https://doi.org/10.1007/BF00176342
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00176342